News from us worldmeds A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 01, 2019, 08:17 ET FDA approves the reintroduction of Zelnorm™ (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in women under 65

US WorldMeds has announced that Sloan Pharma, S.a.r.l., a subsidiary of US WorldMeds Holdings, LLC, has received approval from the U.S. Food and Drug ...


Sep 04, 2018, 17:29 ET US WorldMeds And Salix Pharmaceuticals To Highlight Clinical Data For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine) At 2018 PAINWeek Conference

US WorldMeds and Salix Pharmaceuticals, one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment...


Jun 26, 2018, 08:00 ET Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine)

US WorldMeds, LLC and Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC ("Salix"), one of the largest specialty...


Nov 21, 2017, 07:05 ET U.S. FDA Accepts Regulatory Submission and Grants Priority Review for US WorldMeds' Lofexidine

US WorldMeds today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review of the New Drug Application...


Jul 06, 2010, 04:45 ET US WorldMeds Announces the Launch of Revonto™ (dantrolene sodium for injection)

US WorldMeds is proud to announce the launch of Revonto™ (dantrolene sodium for injection), the first patented scientific advancement in the...